Quick Notes: 483 Edition — Feb. 1, 2024

Lapses in digital security, missed report deadlines, and a complete lack of quality oversight earned manufacturers some notable 483s. And here’s a first: How about getting written up for being too clean?
Source: Drug Industry Daily